GLIS3 and type 2 diabetes mellitus: Previous studies have shown that GLIS3 knockdown accelerates β-cell apoptosis, which is further exacerbated by proinflammatory cytokines or palmitate, potentially contributing to β-cell loss in T2DM [180].